FBR Capital Maintains a 'Market Perform' on AMD (AMD); PC Checks Still Sluggish, but AMD May Benefit from Intel Recall Issue
Get Alerts AMD Hot Sheet
Price: $123.75 +1.20%
Rating Summary:
46 Buy, 18 Hold, 3 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 15 | Down: 15 | New: 16
Rating Summary:
46 Buy, 18 Hold, 3 Sell
Rating Trend: Down
Today's Overall Ratings:
Up: 15 | Down: 15 | New: 16
Join SI Premium – FREE
FBR Capital maintains a 'Market Perform' on AMD (NYSE: AMD), PT $10.
FBR analyst says, "Checks with the top six notebook ODMs have deteriorated of late, with 1Q notebook builds downticking slightly from –10.5% QOQ to –11% QOQ, and with 2Q builds downticking from an optimistic +15% QOQ (which we said was likely to be reduced) to +7% QOQ, worse than expected. While notebook demand could improve, and builds could get ratcheted up by June, our contacts suggest Intel's Sandy Bridge products are not stimulating as much end demand as expected, likely impacting AMD too. For AMD, we think 1Q11 revenues tracked at or above the high end of guidance of flat to slightly down QOQ (versus $1.65B in 4Q and versus the Street's $1.62). That said, original revenue guidance may have been too optimistic with notebook builds set to fall 11% QOQ in 1Q, and with desktop builds likely to fall by 5%–7% QOQ. So, if AMD does achieve the high end of revenue guidance, or potentially better, the upside is likely short term in nature and due to customers turning to AMD for product when Intel's Sandy Bridge was less available due to the chipset bug recall. For 2Q, we think AMD's revenues will fall QOQ given its 14th week in 1Q, Intel (Nadaq: INTC) chipset goodness unwinding, and sluggish desktop builds, still rather unexciting.
For more ratings news on AMD click here and for the rating history of AMD click here.
Shares of AMD closed at $8.79 yesterday.
FBR analyst says, "Checks with the top six notebook ODMs have deteriorated of late, with 1Q notebook builds downticking slightly from –10.5% QOQ to –11% QOQ, and with 2Q builds downticking from an optimistic +15% QOQ (which we said was likely to be reduced) to +7% QOQ, worse than expected. While notebook demand could improve, and builds could get ratcheted up by June, our contacts suggest Intel's Sandy Bridge products are not stimulating as much end demand as expected, likely impacting AMD too. For AMD, we think 1Q11 revenues tracked at or above the high end of guidance of flat to slightly down QOQ (versus $1.65B in 4Q and versus the Street's $1.62). That said, original revenue guidance may have been too optimistic with notebook builds set to fall 11% QOQ in 1Q, and with desktop builds likely to fall by 5%–7% QOQ. So, if AMD does achieve the high end of revenue guidance, or potentially better, the upside is likely short term in nature and due to customers turning to AMD for product when Intel's Sandy Bridge was less available due to the chipset bug recall. For 2Q, we think AMD's revenues will fall QOQ given its 14th week in 1Q, Intel (Nadaq: INTC) chipset goodness unwinding, and sluggish desktop builds, still rather unexciting.
For more ratings news on AMD click here and for the rating history of AMD click here.
Shares of AMD closed at $8.79 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AMD (AMD) call put ratio 2.5 calls to 1 put as share price up 1.5%
- Abbott Labs (ABT) PT Raised to $135 at Stifel
- Abbott Labs (ABT) PT Raised to $140 at BTIG
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!